Though a cure for melanoma remains elusive, continued research has borne several promising treatment approaches with more targeted drugs that can help lengthen melanoma patients' survival, buying them time until more effective treatments come to light.
Understanding key elements of the sales process is key to managing treatment plans and expectations for many aesthetic procedures.
From branding to business basics, the technology startup companies of Silicon Valley offer lessons for entrepreneurs including core aesthetic medicine specialists, an expert says.
Are you a dermatologist using social media to market your practice? Wondering which metrics you should be paying attention to? The answer is a lot easier than you think.
New research suggests botulinum toxin type A has anti-depressive qualities along with its well-known cosmetic effects.
New York dermatologist Mark Lebwohl, M.D., was named president-elect of the American Academy of Dermatology at the academy’s 72nd annual meeting recently.
The Senate passed another one-year fix to the sustainable growth rate (SGR) formula, to the dismay of the American Academy of Dermatology Association and numerous other physician advocate groups.
Scars happen. Doing a routine skin biopsy, performing a surgical facial rejuvenation treatment or Mohs surgery - dermatologists and cosmetic surgeons cause scars. But they can also treat them.
On the final day of the 72nd Annual Meeting of the American Academy of Dermatology, clinicians shared clinical pearls regarding psoriasis comorbidities, isotretinoin dosing for acne and how to treat patients with body dysmorphic disorder.
In the battle against melanoma, a new test has shown that it can identify primary cutaneous melanomas that are likely to metastasize in patients who had negative sentinel lymph node biopsies (SLNB). Data were presented at the 72nd Annual Meeting of the American Academy of Dermatology.
There is a misconception that people with skin of color are not at risk of skin cancer, and dermatologists are responsible for better educating themselves and their patients about this danger, says an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
In discussing tropical skin ailments that can affect children, Scott A. Norton, M.D., presented cases at the 72nd Annual Meeting of the American Academy of Dermatology using a “Jeopardy” format that required students in the audience to frame their diagnoses as questions based on the symptoms outlined.
A new study strongly links pulmonary complications to survival rates among scleroderma patients.
The Food and Drug Administration has approved an oral medication, Otezla (apremilast, Celgene) for the treatment of adult patients with active psoriatic arthritis.
Smart fractional technology represents an exciting development for medical treatments with fractional lasers, says an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
Active chemicals found in the neem tree (Azadirachta indica) have important benefits for a variety of skin disorders, according to one expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
When patients present with hair loss, dermatologists should focus most heavily on patient histories, according to an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
Selecting the appropriate drug category is important to effectively manage itch, Sarina Elmariah, M.D., Ph.D., told attendees at the 72nd Annual Meeting of the American Academy of Dermatology.
Biologic drugs are being extensively explored in medicine, but their use in pediatric patients remains uncharted territory, according to an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
Dermatology can be the target of some unnecessarily negative attitudes from other medical specialties regarding revenue. But some "questionable behavior" by some in the specialty should cause others to more closely scrutinize what procedures they are selecting to perform, according to the incoming president of the American Academy of Dermatology.
When presented with a patient suffering from itching, dermatologists should consider treatments other than topical and oral medications, according to an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
In the search for rosacea treatments, topical ivermectin 1 percent cream met its safety endpoints in two pivotal trials that included a total of 910 actively treated subjects, Galderma announced at the 72nd Annual Meeting of the American Academy of Dermatology.
When addressing onychomycosis caused by cosmetic procedures, says Zoe D. Draelos, M.D., cuticle removal represents a key culprit. Dr. Draelos spoke about onychomycosis treatment options at the 72nd Annual Meeting of the American Academy of Dermatology.
You may think you know enough about facial fillers, but Jill Hessler, M.D., has some things to share with you during her upcoming presentation at the 2014 Vegas Cosmetic Surgery and Aesthetic Dermatology meeting in June.
Rhode Island Hospital is the first in the United States to use Google Glass in an emergency department. During a six-month study, researchers will examine the effectiveness of the wearable streaming audio/video device during consultations with consenting patients requiring a dermatologist.
By a 238 to 181 vote, the House of Representatives approved legislation Friday to repeal Medicare’s sustainable growth rate (SGR).
The use of pyrethrins and pyrethoid-based products to treat head lice may have helped to create selection pressure for resistant strains of the pest in North America, according to new research.
Illegal fillers can have devastating effects on a patient’s body and can be extremely hard to try to correct any resulting disfigurement.
A new study suggests that triple protection factor broad-spectrum sunscreen 50 (TPF50) is more effective than traditional sunscreens in preventing sun damage to the skin and nonmelanoma skin cancer.
Results of a new study suggest that a drug commonly prescribed to patients with cancer - including advanced melanoma - can halt the progress of the disease for up to two years.
